New Non-Opioid Pain Drug with Gets Mixed Clinical Trial Results: Stock Tumbles
Cara Therapeutics, Inc. (Nasdaq: CARA) saw its stock plunge by nearly 40% (as of this writing) when its new non-opioid drug, oral CR845, received mixed…
CR485
What You Don't Know Can Hurt You